跳至主要内容
临床试验/NL-OMON56325
NL-OMON56325尚未招募不适用

ProVag - The effect of oral probiotics intake on the vaginal microbiota composition - ProVag

Academisch Ziekenhuis Maastricht0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age 18 - 43 years - Primary or secondary infertility with a IVF indication -
  • Non-smoker - Low* VMB profile, as measured by the ReceptIVFity score - Signed
  • informed consent * Definition of ReceptIVFity Low profile (Koedooder R 2019): -
  • Relative Lactobacillus load <20% and/or - Relative L. jensenii load >35% and/or
  • - Presence of G. vaginalis IST1 and/or - Relative Proteobacteria load >28%

排除标准

  • - Use of oral/vaginal antibiotics during the 6 weeks before (and up to)
  • enrolment. Antibiotics use during the study does not lead to exclusion, but
  • will be monitored during follow-up visits.
  • - Use of other oral or vaginal probiotics at enrolment and during the study
  • - Use of hormonal treatment other than the IVF course
  • - Pregnant at enrolment
  • - Genital symptoms at enrolment
  • - With history of adverse reaction/allergy to any of the content in the
  • probiotic or placebo
  • - Serious illnesses, hospitalized (or recently hospitalized) or immune
  • compromised, specified to: usage of immune suppressants, immune deficiency
  • disorders and disorders with a disrupted intestinal barrier
  • - Undergoing Pre-implantation Genetic Testing (PGT)

研究者

相似试验